Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Matthew J Smalley
Affiliation
European Cancer Stem Cell Research Institute, Cardiff University
ORCID
Career Start Year
1998
Papers
90
H Index
40
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36936664
Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models.
Cancer Res Commun
2023
37686600
NOTCH and AKT Signalling Interact to Drive Mammary Tumour Heterogeneity.
Cancers (Basel)
2023
37231594
Epidemiology of mammary tumours in bitches under veterinary care in the UK in 2016.
Vet Rec
2023
37365662
Dog breeds and conformations predisposed to osteosarcoma in the UK: a VetCompass study.
Canine Med Genet
2023
36961631
Associations Between Dog Breed and Clinical Features of Mammary Epithelial Neoplasia in Bitches: an Epidemiological Study of Submissions to a Single Diagnostic Pathology Centre Between 2008-2021.
J Mammary Gland Biol Neoplasia
2023
34896918
Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.
Biosens Bioelectron
2022
34003256
Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
Dis Model Mech
2021
33750475
Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control study.
Canine Med Genet
2021
34503160
A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells.
Cancers (Basel)
2021
31566837
Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications.
Adv Mater
2020
34220409
Coupling Nanostructured Microchips with Covalent Chemistry Enables Purification of Sarcoma-Derived Extracellular Vesicles for Downstream Functional Studies.
Adv Funct Mater
2020
32017048
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
Clin Pharmacol Ther
2020
33097539
Supramolecular nanosubstrate-mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies.
Sci Adv
2020
32637655
Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.
NPJ Precis Oncol
2020
32630372
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
Int J Mol Sci
2020
32793804
Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies.
NPJ Breast Cancer
2020
33023965
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection.
Cancer Immunol Res
2020
32895384
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.
Nat Commun
2020
31080552
Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in <i>Brca2</i>-mutant mammary tumours.
Oncotarget
2019
31291912
APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression.
BMC Cancer
2019
31565541
Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells.
Curr Obstet Gynecol Rep
2019
31392269
Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells.
Sci Adv
2019
30892008
Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
ACS Appl Mater Interfaces
2019
29551650
NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.
Adv Drug Deliv Rev
2018
30590041
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.
Cell Rep
2018
29581176
Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant Growth.
Cancer Discov
2018
28870991
The receptor protein tyrosine phosphatase PTPRB negatively regulates FGF2-dependent branching morphogenesis.
Development
2017
29446000
See One, Do One, Teach One: A Practical Course on Methods in Mammary Gland Biology.
J Mammary Gland Biol Neoplasia
2017
29262329
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.
Cell Rep
2017
29134654
PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
J Pathol
2017
27782124
Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids.
Nat Commun
2016
26650685
Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression.
Biomaterials
2016
25803307
Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.
PLoS One
2015
26489514
Runx2 contributes to the regenerative potential of the mammary epithelium.
Sci Rep
2015
26331886
Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development.
Curr Protoc Pharmacol
2015
26193872
ERrrr⿦where are the progenitors? Hormone receptors and mammary cell heterogeneity.
J Mammary Gland Biol Neoplasia
2015
25849541
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer.
Breast Cancer Res
2015
25692405
Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.
J Pathol
2015
24586114
Developmental programming mediated by complementary roles of imprinted Grb10 in mother and pup.
PLoS Biol
2014
24615332
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.
J Pathol
2014
22554712
Breast cancer stem cells: obstacles to therapy.
Cancer Lett
2013
24286369
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Breast Cancer Res
2013
23810554
Aurora A kinase regulates mammary epithelial cell fate by determining mitotic spindle orientation in a Notch-dependent manner.
Cell Rep
2013
23506684
Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
Breast Cancer Res
2013
23154416
Protein tyrosine phosphatase 1B restrains mammary alveologenesis and secretory differentiation.
Development
2013
22562252
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
Oncogene
2013
21765473
c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Oncogene
2012
23227978
Who do they think they are? Wnt-responsive cells reveal their family trees.
Breast Cancer Res
2012
22971267
Slugging their way to immortality: driving mammary epithelial cells into a stem cell-like state.
Breast Cancer Res
2012
22975324
Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis.
Dev Cell
2012
1 - 50 of 90
Column Actions
Search
Recommended Authors
Simona Cristea
Dana-Farber Cancer Institute
Career Start Year
2016
Number of shared co-authors
0
Radek Fedr
Institute of Biophysics of the Czech Academy of Sciences
Career Start Year
2013
Number of shared co-authors
0
Pirashaanthy Tharmapalan
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
2012
Number of shared co-authors
0
Hartland W Jackson
Lunenfeld-Tanenbaum Research Institute
Career Start Year
2010
Number of shared co-authors
1
Andrew S Goldstein
University of California los angeles
Career Start Year
2008
Number of shared co-authors
1
Hui Fang
Beihua University
Career Start Year
2007
Number of shared co-authors
1
Purna A Joshi
Princess Margaret Cancer Centre
Career Start Year
2006
Number of shared co-authors
1
Daniel Schramek
University of Toronto
Career Start Year
2005
Number of shared co-authors
1
Mona Shehata
University of Cambridge
Career Start Year
2004
Number of shared co-authors
1
Donghui Cheng
University of California los angeles
Career Start Year
2003
Number of shared co-authors
1
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year
2002
Number of shared co-authors
0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year
2002
Number of shared co-authors
0
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year
2002
Number of shared co-authors
7
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
2000
Number of shared co-authors
1
Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Career Start Year
1999
Number of shared co-authors
1
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year
1999
Number of shared co-authors
6
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1997
Number of shared co-authors
1
Michael T Lewis
Baylor College of Medicine
Career Start Year
1996
Number of shared co-authors
6
Alexander D Borowsky
University of California Davis Health
Career Start Year
1995
Number of shared co-authors
6
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
1
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1992
Number of shared co-authors
1
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year
1992
Number of shared co-authors
5
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1991
Number of shared co-authors
3
Eldad Zacksenhaus
University of Toronto
Career Start Year
1988
Number of shared co-authors
0
Melissa H Wong
Oregon Health & Science University
Career Start Year
1988
Number of shared co-authors
0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
0
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Career Start Year
1985
Number of shared co-authors
5
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1984
Number of shared co-authors
2
Alfredo A Molinolo
University of California
Career Start Year
1984
Number of shared co-authors
0
Sunil R Lakhani
University of Queensland
Career Start Year
1983
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers
11
Hsian-Rong Tseng
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers
11
Edwin M Posadas
Cedars-Sinai Medical Center
Co-authored papers
5
Vatche G Agopian
David Geffen School of Medicine , University of California los angeles
Co-authored papers
5
Alan Mackay
Co-authored papers
5
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
5
Clare M Isacke
Co-authored papers
4
Yu Jen Jan
Cedars-Sinai Medical Center
Co-authored papers
4
Kara L Britt
Co-authored papers
3
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
2
Li-Ching Chen
College of Life Science, China Medical University Taichung 406040
Co-authored papers
2
Jie-Fu Chen
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers
1
Huiying Li
University of California irvine
Co-authored papers
1
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Co-authored papers
1
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers
1
Peter Kuhn
University of Tubingen
Co-authored papers
1
Bryan Moy
Co-authored papers
1
Phillip G Febbo
Illumina Inc.
Co-authored papers
1
Sean E Hanlon
Drew University, National Institutes of Health, Rutgers University New Brunswick, University of North Carolina at Chapel Hill
Co-authored papers
1
Jake Vinson
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers
1
Jonathan Franca-Koh
J Craig Venter Institute
Co-authored papers
1
Andrew Schade
Co-authored papers
1
Robert L Grossman
University of Chicago
Co-authored papers
1
Matthew Ryder
Co-authored papers
1
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers
1
Carolyn Compton
College of American Pathologists
Co-authored papers
1
Daniel L Edelstein
Sysmex Inostics Inc.
Co-authored papers
1
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers
1
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers
1
1 - 30